Side Effects of Drugs Annual Side Effects of Drugs Annual Series

Langue : Anglais

Directeur de Collection : Ray Sidhartha D.

Couverture de l’ouvrage Side Effects of Drugs Annual

Résumé
Sommaire
Lectorat
Biographie
Commentaire

Side Effects of Drugs Annual: A Worldwide Yearly Survey of New Data in Adverse Drug Reactions, Volume 42, first published in 1977, and continually published as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs, presents clinicians and medical investigators with a critical survey of new data and trends in adverse drug reactions and interactions. Topics covered in this new release include Central Nervous System Stimulants and Drugs that Suppress Appetite, Antidepressants, Lithium, Drugs of Abuse, Hypnotics and Sedatives, Antipsychotic Drugs, Antiepileptics, Opioid Analgesics and Narcotic Antagonists, Anti-Inflammatory and Antipyretic Analgesics and Drugs Used in Gout, and much more.

1. Central nervous system stimulants and drugs that suppress appetite
Dushyant Kshatriya and Nicholas T. Bello
2. Antidepressant medications
Emily Leppien, Tamara Bystrak and Bennett Doughty
3. Lithium
Holly Lowe, Jason Bowell, Jaqueline Go, Taylor LaFrance, Ashley D. Riner, Sarah M. Arthur, Sidhartha D. Ray and Connie F. Rust
4. Drugs of abuse
Katelynn M. Mayberry, Jenna Bloemer and Sidhartha D. Ray
5. Drugs used in the treatment of Alzheimer’s disease
Jenna Bloemer
6. Sedatives and hypnotics
Parna Haghparast, Michael Pondrom and Sidhartha D. Ray
7. Antipsychotic agents
Ashakumary Lakshmikuttyamma, Parna Haghparast, Emily Hajjar, Timothy Smith and Parisa Pooresfehani
8. Anti-epileptic medications
Cucnhat Phung Walker and Sidhartha D. Ray
9. Opioid analgesics and narcotic antagonists
Ashley Sowards, Michael G. O’Neil, Justin G. Kullgren and Jennifer M. Silva
10. Anti-inflammatory and antipyretic analgesics and drugs used in gout
Brittany Long and Mark E. Olah
11. General anesthetics and therapeutic gases
Mark Lavery and Alison Hall
12. Local anesthetics
Danielle D Pete and Manoranjan S D’Souza
13. Antihistamines (H1 receptor antagonists)
Cheryl K. Horlen and Johnathan Cuevas
14. Drugs that act on the respiratory tract
Dinesh Yogaratnam, Katherine M. Carey, Valerie Coppenrath, Aimee Dawson, Daniel Havkins, Amy BW LaMothe and Ann M. Lynch
15. Positive inotropic drugs and drugs used in dysrhythmias
Kerry Anne Rambaran, Rebecca Tran and Saeed Alzghari
16. Beta adrenergic antagonists and antianginal drugs
Lindsey M. Stever, Lindsey Foltanski, Mallory L. Moore, Carrie Anderson and Brooklyn Nelson
17. Drugs acting on the cerebral and peripheral circulations
Keaton S. Smetana, Brian P. Goetz and Casey C. May
18. Antihypertensive drugs
Rebecca Kavanagh
19. Diuretics
Saeed Khaled Alzghari, Kerry Anne Rambaran and Sidhartha D. Ray
20. Metals and metal antagonists
Joshua P. Gray and Sidhartha D. Ray
21. Antiseptic drugs and disinfectants
Dirk W. Lachenmeier
22. Beta-lactams and tetracyclines
Rebecca A. Buckler, Meghan T. Mitchell and Samantha R. Phillips
23. Miscellaneous antibacterial drugs
Jason M. Cota and Taylor M. Benavides
24. Antiprotozoal
Bejoy Paul Maniara, Ian Wells and Sidhartha D. Ray
25. COVID-19 pandemic: Case studies and perspectives
Michael Liu
26. Antituberculosis and antileprosy medications
Igho J. Onakpoya
27. Antihelminthic drugs
Igho J. Onakpoya
28. Blood, blood components, plasma, and plasma products
Seohyun (Claudia) Choi, Michael Casias, Danielle Tompkins and Jimmy Gonzalez
29. Drugs that affect blood coagulation, fibrinolysis and hemostasis
Seohyun (Claudia) Choi, Jessica Wilczynski, Danielle Tompkins and Jimmy Gonzalez
30. Gastrointestinal drugs (Jan 2019–Dec 2019)
Lindsey Sellers Coppiano and Dianne May
31. Drugs that act on the immune system: Immunosuppressive and immunostimulatory drugs
Cucnhat Walker and Sidhartha D. Ray
32. Corticotrophins, corticosteroids, and prostaglandins
Jose Ruiz, Maya Watford, Essie Samuel, Sidhartha D. Ray and Vicky Modi
33. Sex hormones, related compounds and hormonal contraceptives including miscellaneous hormones
Ian Wells, Sandy Ezzet, Namarta Kalia, Kenneth Pawa and Sidhartha D. Ray
34. Thyroid hormones, iodine and iodides, and antithyroid drugs
Ian Wells, Sandy Ezzet, Namarta Kalia, Chana E. Shenas and Sidhartha D. Ray
35. Insulin and other hypoglycemic drugs
Laura A. Schalliol and Jasmine M. Pittman
36. Drugs that affect lipid metabolism
Amanda Phoenix, Charnicia E. Huggins and Kevin Pao
37. Radiological contrast agents and radiopharmaceuticals
Manoranjan S D’Souza, Rachel Miguel and Sidhartha D. Ray
38. Drugs used in ocular treatment
Robert S. Duszak, Emily R. Carr, Rajni K. Acharya and Lisa V. Stottlemyer
39. Complementary and alternative medicine
Renee A. Bellanger and Christina M. Seeger
40. Cytostatic agents
Adrienne T. Black, Daniel Zinkovsky, Shelly Ray and Sidhartha D. Ray

Pharmacologists, clinicians, pharmaceutical companies, clinical toxicologists, clinical pharmacologists and medical libraries.

Sidhartha D. Ray, PhD, FACN serves as a Senior Professor of Pharmaceutical and Biomedical Sciences at The Touro College of Pharmacy at Manhattan, New York. Prior to this he served as Professor of Pharmaceutical Sciences for nearly 2 decades at the Arnold & Marie Schwartz College of Pharmacy and Health Sciences of Long Island University, New York, and as the founding chair of Pharmaceutical Science department at Manchester University College of Pharmacy, Indiana, USA. He has been in the health sciences academy for over 35 years mainly focusing on pharmacy teaching, research and service. Dr. Ray's research program focus on drug & chemical induced organ toxicology, mechanistic & molecular toxicology, adverse drug reaction mechanisms, side effects of a number of therapeutically relevant drugs and environmentally significant chemicals. Over the last two decades, Dr. Ray’s seminal discoveries have provided clear understandings on the dynamic role of apoptosis, necrosis and necraptosis during organotoxic reactions and have influenced the development of safety measures for a stunning variety of xenobiotics, phytochemicals and nutraceuticals. He is internationally recognized as a leader in the scientific community and was one of the front runners in exploring mechanisms of drug and chemical-induced programmed and un-programmed cell death in in-vivo models. His landmark studies on the interplay of bcl-2, bcl-xl, p53, bad and bax during acetaminophen induced cell death and its prevention by grape seed proanthocyanidin extract has earned worldwide citations. His peer recognition and acknowledged service contributions are reflected by his election into multiple international professional organizations, such as the Society of Toxicology (SOT), Society of Free Radical Biology & Medicine (SFRBM), American Society of Pharmacology & Experimental Therapeutics (ASPET), American Association of Colleges of Pharmacy (AACP) and American College of Nutrition (ACN). Dr. Ray is an Associate

Provides a critical yearly survey of the new data and trends regarding the side effects of drugs
Authored and reviewed by worldwide pioneers in the clinical and practice sciences
Presents an essential clinical guide on the side effects of drugs for practitioners and healthcare professionals alike